Baxter International | BAX - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.06B 69M 2026-03
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.69M 242K 2026-03
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 25.86B 1.63B 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.34B 132.6M 2025-12
Fresenius EUR 18.62B 320M 2025-09
Globus Medical USD 4.57B 174.42M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
ICU Medical USD 2.12B 3.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Quest Diagnostics USD 7.37B 196M 2026-03
Smith & Nephew USD 5.54B 331M 2025-12
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Terumo JPY 1.52T 84.79B 2025-12
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03